CPT 1070F: Performance/Status Summary Classification

CPT code 1070F is a CPT Category II-style performance/status code for documenting a summary classification; the provided input did not include a descriptive summary. Nationally, Category II and status-oriented CPT codes are used to standardize reporting for quality measurement and administrative tracking across payers and care settings. This type of code matters because consistent use supports population-level quality metrics, payer reporting, and administrative workflows.

Key payers covered in the discussion include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what the code represents, the service context where it is typically applied, and what to expect in payor coverage considerations. The publication covers benchmark-oriented elements and policy implications relevant to national reporting and claims processing, summarizes clinical context where applicable, and identifies gaps in the input data.

Data not provided in the input (such as specific service definitions, common modifiers, associated taxonomies, ICD-10 links, and related codes) are noted as unavailable. The article is intended to orient payers, billing professionals, and policy analysts to the code’s role in quality reporting and administrative classification.

Billing Code Overview

CPT code 1070F indicates a summary status classification where no summary description was provided in the input. Based on the code format, this is a CPT Category II-style alphanumeric code used for performance tracking and quality measurement rather than a procedure or service. Service Type: Data not available in the input. Typical Site of Service: Data not available in the input.

Clinical Context

A typical patient is an adult presenting to a dermatology clinic with a suspicious cutaneous lesion (e.g., rapidly changing pigmented lesion, irregular border, or ulcerated nodule) requiring full-thickness biopsy for definitive histopathologic diagnosis. The clinical workflow includes patient evaluation, consent, local anesthesia administration, lesion excision or punch/shave technique to obtain adequate tissue, hemostasis, wound closure or dressing, specimen labeling and submission to pathology, and brief post-procedure instructions. The procedure is usually performed in an outpatient clinic or ambulatory surgery center under local anesthesia. Common clinical indications include suspected melanoma, basal cell carcinoma, squamous cell carcinoma, or chronic non-healing ulcer requiring tissue diagnosis.

Coding Specifications

Modifier	Description	When to Use
`25`	Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure	Use when a distinct E/M visit is medically necessary and documented on the same date as the biopsy/procedure
`59`	Distinct procedural service	Use when two procedures on the same day are separate and distinct (e.g., two biopsies at different anatomic sites)

Taxonomy Code	Specialty	Notes
207Q00000X	Dermatology	Dermatologists most commonly perform skin biopsies and excisions
208000000X	General Practice	Primary care physicians may perform routine skin biopsies in outpatient settings
207L00000X	Plastic Surgery	Plastic surgeons perform excisions and closures for larger or complex cutaneous lesions
207K00000X	General Surgery	General surgeons perform excisional biopsies for lesions in challenging locations
363L00000X	Pathology	Pathologists handle grossing and microscopic diagnosis of submitted specimens

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`C43.9`	Malignant melanoma of skin, unspecified	Suspicious pigmented lesions may be biopsied to confirm melanoma
`C44.91`	Squamous cell carcinoma of skin, unspecified	Non-healing or suspicious nodules often require biopsy for SCC diagnosis
`C44.01`	Basal cell carcinoma of skin of lip	Common skin cancer where biopsy confirms diagnosis and guides treatment
`L98.0`	Pyoderma gangrenosum	Ulcerative skin conditions may require biopsy to exclude other causes
`L57.0`	Actinic keratosis	Precancerous lesions that may be biopsied when suspicious changes occur

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`11100`	Biopsy of single skin lesion; single technique (e.g., shave, punch, excisional)	Common alternative code for simple skin biopsies; selected based on lesion depth and technique
`11101`	Biopsy of each additional lesion, any method, unless listed elsewhere	Used when multiple separate lesions are biopsied during the same encounter
`12001`	Repair, simple, wounds of scalp, neck, axillae, external genitalia, trunk and/or extremities; 2.5 cm or less	Used when wound closure after excisional biopsy requires simple layered repair
`13132`	Repair, complex, scalp, arms, and/or legs; 21.1 cm to 30.0 cm	Used when larger or complex closures follow excision of significant skin lesions
`88305`	Level IV surgical pathology, gross and microscopic examination	Common pathology billing code for routine evaluation of skin biopsy specimens
`96408`	Chemotherapy administration, intravenous, percutaneous, when intralesional therapy is required	May relate when intralesional therapy is administered following biopsy findings (context-specific)

OpenPayer

Summary & Overview